Drug Information
| Drug General Information | Top | |||
|---|---|---|---|---|
| Drug ID |
DRT2P7
|
|||
| Drug Name |
GEN-1
|
|||
| Drug Type |
Gene therapy
|
|||
| Indication | Ovarian cancer [ICD-11: 2C73; ICD-10: C56; ICD-9: 183] | Phase 2 | [1], [2], [3] | |
| Company |
Celsion
|
|||
| Target and Pathway | Top | |||
|---|---|---|---|---|
| Target(s) | Interleukine 12 (IL-12) | Target Info | Replacement | [4] |
| References | Top | |||
|---|---|---|---|---|
| REF 1 | Clinical pipeline report, company report or official report of the Pharmaceutical Research and Manufacturers of America (PhRMA) | |||
| REF 2 | Clinical pipeline report, company report or official report of the Pharmaceutical Research and Manufacturers of America (PhRMA) | |||
| REF 3 | Clinical pipeline report, company report or official report of the Pharmaceutical Research and Manufacturers of America (PhRMA) | |||
| REF 4 | Clinical pipeline report, company report or official report of Celsion. | |||
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.